top of page
A Closer Look
Line separator

RESEARCH GRANT AWARDS

AWARDS LIST.

Totals by Year

2022 - $689,966

2021 - $749,812

2020 - $630,000

2019 - $690,000

2018 - $750,000

2017 - $747,772

2016 - $720,000

2015 - $840,000

2014 - $810,000

2013 - $808,500

2012 - $720,000

2011 - $599,780

2010 - $438,000

2009 - $435,000

2008 - $619,993

2007 - $232,600

2006 - $384,551

Leonora Slatnick, MD

2021

$30,000

Biomarker Development for Sepsis in Pediatric Oncology Patients

Paul Jedlicka, MD, PhD

2021

$30,000

Understanding the metastasis-promoting cistrome in Ewing Sarcoma

Siddhartha Mitra, PhD

2021

$30,000

Development of Chimeric Antigen Receptor Expressing macrophages and microglia to target pediatric glioblastoma

Santos Franco, PhD, Siddhartha Mitra, PhD and Adam Green, MD

2021

$60,000

Development of In utero driven Mouse Models of Diffused Midline Gliomas to study the tumor immune interactions in Pediatric Midline Gliomas

Carol Sartorius, PhD

2021

$30,000

Lipodependence of endocrine resistant breast cancer as a therapeutic target

Takeshi Yamauchi, PhD

2021

$30,000

Non-UV risk factors of melanoma

John Tentler, PhD

2021

$30,000

Cancer Research Summer Fellowship Program

Jennifer Matsuda, PhD and James Scott-Browne, PhD

2021

$60,000

Genetic manipulation of human T cell transcriptional programs to improve cancer immunotherapy

Andrew Getahun, PhD and John Cambier, PhD

2021

$60,000

Identification of novel inhibitory checkpoint receptors

Nathan Dahl, MD

2021

$30,000

Unlocking the combination: Potentiation of radiation-induced antitumor effect using clinically-relevant BH3 mimetics to effectively target DIPG

Rajeev Vibhakar, MD, PhD, MPH

2021

$30,000

Role of BMI1 in SMARB1 deleted ATRTs

Alisa Lee-Sherick, MD and C. Wyatt Shields, PhD

2021

$60,000

Assessment of Cell Types for Delivering MerTK Inhibitors to Sarcomas

Sujatha Venkataraman, PhD

2021

$30,000

Novel CAR T cell therapies to target metastatic Ewing Sarcoma

Adam Green, MD and Natalie Serkova, PhD and Mark Borden, PhD

2021

$60,000

MRI-Guided Focused Ultrasound to Improve Treatment of DIPG

Carlo Marchetti, PhD and Mayumi Fujita, MD, PhD

2021

$60,000

Identifying the role of NLRP3 in immunotherapy resistant melanomas

Matthew J. Sikora, PhD

2021

$30,000

Targeting an unexplored DNA repair deficiency and radiosensitivity in lobular breast cancer

Satyanarayan Rao, PhD

2021

$30,000

Using transcription factors to map tumor state and microenvironment

Masanori Hayashi, MD

2021

$30,000

Preclinical Investigation of BCOR rearranged solid tumors

Elizabeth Kessler, MD

2021

$29,812

Validation of a patient-reported tool to screen for geriatric impairments predictive of potential frailty in cancer patients

Swati G. Patel, MD, MS

2020

 $     30,000

Identification of Hereditary Cancer Syndromes through Advanced Polyps

Raphael Nemenoff, PhD & Erin Schenk, MD, PhD

2020

 $     60,000

The Tumor Microenvironment as a Critical  Regulator of Targeted Therapy in ALK Positive Lung Cancer

Rebecca Schweppe, PhD

2020

 $     30,000

The role of Nuclear FAK in Thyroid Cancer

Ryan Marker, PhD

2020

 $     30,000

Feasibility and effectiveness of an Innovative exercise program to reduce fatigue in rural cancer survivors

Zdenek Andrysik PhD

2020

30,000

Exploring strong synergism of targeted p53 activation and translation inhibition in colorectal cancer.

Diana M. Cittelly, PhD

2020

 $     30,000

Function of Ephrin B Signaling in Breast cancer brain metastasis

Sujatha Venkataraman PhD & Adam Green, MD & Mark Kohler, MD, PhD

2020

 $     60,000

Engineering Logic-Gated DC99 CAR to selectively target H3K27M-DIPG tumor cells and to protect normal cells

Mayumi Fujita, MD, PhD & Charles A. Dinarello, MD

2020

 $     60,000

The role of alpha-1 antitrypsin in cancer immunotherapy

Molishree Joshi, PhD

2020

 $     30,000

A novel CRISPR-mediated tumor targeting strategy for Liiposarcoma

Breelyn Wilky, MD & Eduardo Davila, PhD

2020

 $     60,000

Toxicity and Biodistribution of CD*:MyD88 Engineered Autologous T Cells In Mouse Models of Melanoma and Fibrosarcoma

Zachary Graff, MD

2020

 $     30,000

Development of Bispecific CAR T-cells for the Prevention of Lineage Switch in KMT2A-rearranged Leukemia

Christine Towers, PhD

2020

 $     30,000

Identifying novel regulators of mitochondrial turn over

Paula Jedlicka, MD, PhD

2020

 $     30,000

Understanding and targeting highly metastatic EWS/FLi1-low cells in Ewing Sarcoma

Maureen Lynch, Phd & Philip Owens, PhD

2020

 $     60,000

The role of exercise in breast cancer bone metastasis

Matthew Tallaferro, PhD

2020

 $     30,000

Control of cell division through centrosomal RNA localization

Senthilnath Lakshmana Chetty, PhD

2020

 $     30,000

Combining radiation and Immunotherapy to target diffuse midline gliomas with the H3K27M mutation

Mayumi Fujita, MD, PhD  & Donald Backos, PhD

2019

 $              60,000

Somatic mutations in inflammasome genes in melanoma

Jay Hesselberth, PhD

2019

 $              30,000

Single-cell methods to measure functional heterogeneity

John Tentler, PhD

2019

 $              30,000

Cancer Research Summer Fellowship Program

Isabel Schlaepfer, PhD

2019

 $              30,000

Role of fat oxidation via CPT1A in immunological response to prostate cancer

Neil Box, PhD

2019

 $              30,000

Regulation of p53 in tanning

Heather Brechbuhl, PhD

2019

 $              30,000

Defining reversible tumor traits in the obese microenvironment

Matthew Sikora, PhD

2019

 $              30,000

Defining MDC1 as a central regulator of estrogen receptor and DNA repair in lobular carcinoma

Paul Norman, PhD

2019

 $              30,000

Natural Killer cells can protect from developing leukemia

Adam Mueller, MD, PhD

2019

 $              30,000

Investigating crosstalk between ADAM10 and EphrinB2/EPHB4 in mediating radiation induced fibrosis, invasion and metastasis in pancreatic cancer

Cem Altunbas, PhD

2019

 $              30,000

High-fidelity volumetric imaging for quantitative treatment monitoring and modifications in radiation therapy

Sujatha Venkataraman, PhD and Mark Kohler, MD, PhD

2019

 $              60,000

CD99 targeting CAR T cells as a novel therapy for H3K27M mutant DIPG

Yiqun Shellman, PhD & Martin McCarter, MD

2019

 $              60,000

Targeting anti-apoptotic pathways to improve immunotherapies for melanoma

Zachary Levi Watson, PhD

2019

 $              30,000

Targeting histone acetylation in PARP inhibitor-resistant ovarian cancer

Shi-Long Lu, MD, PhD and Daniel Frank, PhD

2019

 $              60,000

Mechanism of oral microbiota in head and neck cancer pathogenesis and application for targeted therapy

Carol Sartorius, PhD

2019

 $              30,000

PR-RAR downregulation of protein synthesis and cell growth in breast cancer

Neelanjan Mukherjee, PhD & Daniel Sherbenou, MD, PhD

2019

 $              60,000

Exploiting mRNA translation inhibition for the treatment of relapsed/refractory multiple myeloma

Stephen Keysar, PhD

2019

 $              30,000

Targeting of stemness factors and fusion proteins in salivary gland cancers through inhibition of translation elongation

Rajeev Vibhakar, MD, PhD, MPH

2019

 $              30,000

Role of CDK7 in medulloblastoma

Jessica Lake, MD, MPH

2018

 $     30,000

IPS-derived, CAR-expressing Natural Killer Cells Targeting EGFR on Pediatric Sarcomas

Katja Kiseljak-Vassiliades, DO and Kimberly Jordan, PhD

2018

 $     60,000

Potentiating anti-PD1 Immunotherapy with Mitotane in Adrenocortical Carcinoma

Christopher Lieu, MD and Todd Pitts, MD

2018

 $     60,000

Investigating the role of MEK and non-canonical Wnt inhibition in altering the immune microenvironment in metastatic colorectal cancer

Adwitiya Kar, PhD and Margaret Wierman, MD

2018

 $     30,000

Targeting Maternal Embryonic Leucine Zipper Kinase (MELK) in the first pre-clinical models of Adrenocortical Carcinoma

Martin McCarter, MD

2018

 $     30,000

Improving immune checkpoint inhibitor efficacy by targeting myeloid-derived suppressor cell function

Zhangguo Chen, PhD

2018

 $     30,000

Elucidating mechanisms by which a newly developed HDAC inhibitor sensitizes B cell lymphomas to PD-1 therapy

Benjamin Bitler, PhD

2018

 $     30,000

Investigating the mechanisms of EHMT1/2-dependent PARP inhibitor resistance

Linda Van Dyk, PhD

2018

 $     30,000

Role of CDK4 and CDK6 in gammaherpesvirus oncogenesis

Jennifer Hintzsche, PhD

2018

 $     30,000

Patient-centric Multi-Omics Approach to Identifying Actionable Therapeutics in Cancer

Nicholas Forman, MD

2018

 $     30,000

Characterization of heterogeneous tumor subpopulations in childhood ependymoma

Jennifer DeLuca, PhD

2018

 $     30,000

Targeting Kinetochore Dysfunction in Cancer Cells

David Ryan Ormond MD

2018

 $     30,000

Diffusion tensor image tractography in surgical resection of glioblastoma resection and surgical safety

Courtney Jones, PhD

2018

 $     30,000

Targeting relapse leukemia stem cells through inhibition of NAD synthesis

Raul M. Torres, PhD

2018

 $     30,000

Suppression of human CD8 T cell antigen receptor signaling and cytotoxic activity by lysophosphatidic acid

Maria Jose Contreras, PhD

2018

 $     30,000

Mechanisms of TDM1/radiation-induced toxicity in brain metastases

Mair E.A. Churchill, PhD

2018

 $     30,000

Inhibition of Chromatin Assembly Factor 1 B to Reverse Leukemogenesis

Scott Cramer, PhD and James Costello, PhD

2018

 $     60,000

Targeting the Achilles heel of prostate cancer with loss of CHD1 and MAP3K7

John Tentler, PhD

2018

 $     30,000

Cancer Research Summer Fellowship Program

Jill Slansky PhD

2018

 $     30,000

Functional activation of low-affinity T cells in the tumor

Rebecca Schweppe, PhD

2018

 $     30,000

Cooperative Src and MAP Kinase Signaling in Thyroid Cancer

Nathan Dahl, MD

2018

 $     30,000

Oncogenic Role of the Super Elongation Complex in H3K27M-mutant Diffuse Midline Glioma

David Thomas, PhD and Mark Borden, PhD

2018

 $     30,000

X-Ray Acoustic Computed Tomography Guided Adaptive Radiotherapy

bottom of page